Which funds own CRL
Charles River Laboratories Interna in the Q2 2026 filings. At least 2 of the 91 current managers on file reported a position, worth $704m between them. It is among the largest positions of fewer than a fifth of the current managers on file. The quarter went the other way: 4 managers trimmed or sold out against 1 buying.
- Managers holding
- 2
- at least, of 91 current
- Combined value
- $704m
- as reported
- Opened
- 0
- new this quarter
- Added to
- 1
- already held
- Trimmed or sold out
- 4
- 3 sold out entirely
Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.
Managers reporting a position
Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.
| Manager | Value | Weight | Shares | Change on the quarter | Action |
|---|---|---|---|---|---|
| Harris Associates LP Value · $75.4bn book | $508m | 0.7% | 2,241,144 | +$137m+87,848 | Added |
| Neuberger Berman Group LLC Long-only · $150bn book | $196m | 0.1% | 862,704 | +$45m-11,674 | Trimmed |
Sold out of this quarter
Valued at what the position was worth in the previous filing, because by this one it is gone.
- PDT Partners LLC · Quantitative$3.3m held before
- Verition Fund Management LLC · Multi-strategy$3.1m held before
- Maverick Capital Ltd · Long/short equity$1.4m held before
Ownership through time
At least 12 of the 95 managers whose filings are on file listed CRL in Q2 2026, against 6 in Q2 2013. 2 managers fewer than in Q1 2026: 1 listed it again; 2 sold out, by their own filings; 1 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.
Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.
- Q2 2013: 6
- Q3 2013: 9
- Q4 2013: 9
- Q1 2014: 11
- Q2 2014: 7
- Q3 2014: 10
- Q4 2014: 7
- Q1 2015: 13
- Q2 2015: 10
- Q3 2015: 7
- Q4 2015: 10
- Q1 2016: 13
- Q2 2016: 12
- Q3 2016: 10
- Q4 2016: 12
- Q1 2017: 13
- Q2 2017: 16
- Q3 2017: 14
- Q4 2017: 11
- Q1 2018: 11
- Q2 2018: 9
- Q3 2018: 11
- Q4 2018: 14
- Q1 2019: 11
- Q2 2019: 12
- Q3 2019: 10
- Q4 2019: 10
- Q1 2020: 10
- Q2 2020: 12
- Q3 2020: 12
- Q4 2020: 15
- Q1 2021: 14
- Q2 2021: 14
- Q3 2021: 11
- Q4 2021: 15
- Q1 2022: 15
- Q2 2022: 17
- Q3 2022: 16
- Q4 2022: 11
- Q1 2023: 9
- Q2 2023: 9
- Q3 2023: 10
- Q4 2023: 9
- Q1 2024: 9
- Q2 2024: 7
- Q3 2024: 9
- Q4 2024: 10
- Q1 2025: 12
- Q2 2025: 15
- Q3 2025: 11
- Q4 2025: 16
- Q1 2026: 14
- Q2 2026: 12
- Q2 2013: $199m
- Q3 2013: $335m
- Q4 2013: $379m
- Q1 2014: $503m
- Q2 2014: $377m
- Q3 2014: $529m
- Q4 2014: $417m
- Q1 2015: $625m
- Q2 2015: $302m
- Q3 2015: $258m
- Q4 2015: $396m
- Q1 2016: $460m
- Q2 2016: $479m
- Q3 2016: $532m
- Q4 2016: $549m
- Q1 2017: $559m
- Q2 2017: $953m
- Q3 2017: $948m
- Q4 2017: $959m
- Q1 2018: $867m
- Q2 2018: $590m
- Q3 2018: $725m
- Q4 2018: $655m
- Q1 2019: $910m
- Q2 2019: $839m
- Q3 2019: $662m
- Q4 2019: $783m
- Q1 2020: $778m
- Q2 2020: $1.0bn
- Q3 2020: $1.4bn
- Q4 2020: $1.5bn
- Q1 2021: $2.1bn
- Q2 2021: $2.5bn
- Q3 2021: $2.8bn
- Q4 2021: $2.7bn
- Q1 2022: $1.8bn
- Q2 2022: $1.1bn
- Q3 2022: $1.1bn
- Q4 2022: $1.1bn
- Q1 2023: $864m
- Q2 2023: $755m
- Q3 2023: $475m
- Q4 2023: $536m
- Q1 2024: $664m
- Q2 2024: $385m
- Q3 2024: $898m
- Q4 2024: $1.0bn
- Q1 2025: $1.0bn
- Q2 2025: $1.3bn
- Q3 2025: $1.2bn
- Q4 2025: $2.1bn
- Q1 2026: $2.7bn
- Q2 2026: $3.7bn
Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.
Started in Q2 2026
No manager on file started a position.
Largest increases, by shares
- Fidelity (FMR LLC)3,456,244 to 4,239,752 shares+$178m
- Invesco Ltd2,397,252 to 2,984,785 shares+$133m
- T. Rowe Price Associates Inc1,125,143 to 1,505,370 shares+$86m
- Harris Associates LP2,153,296 to 2,241,144 shares+$20m
Largest decreases, by shares
- Arrowstreet Capital LP737,030 to 278,558 shares-$104m
- Millennium Management LLC934,045 to 486,462 shares-$102m
- Wellington Management Group LLP1,629,401 to 1,288,463 shares-$77m
- MFS Investment Management908,850 to 682,173 shares-$52m
- Moore Capital Management LP43,234 to 3,892 shares-$8.9m
Left it
- PDT Partners LLCwas $3.3m
- Maverick Capital Ltdwas $1.4m
| Manager | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Fidelity (FMR LLC) | Q2 2017 | $1.2bn | $962m | |
| Invesco Ltd | Q2 2013 | $677m | $677m | |
| Harris Associates LP | Q2 2025 | $508m | $508m | |
| T. Rowe Price Associates Inc | Q2 2022 | $525m | $341m | |
| Wellington Management Group LLP | Q3 2013 | $753m | $292m | |
| Citadel Advisors LLC | Q1 2026 | $271m | $271m | |
| Neuberger Berman Group LLC | Q2 2013 | $196m | $196m | |
| MFS Investment Management | Q2 2018 | $560m | $158m | |
| Millennium Management LLC | Q3 2013 | $161m | $110m | |
| Marshall Wace LLP | Q2 2015 | $266m | $78m | |
| Arrowstreet Capital LP | Q3 2017 | $167m | $63m | |
| Moore Capital Management LP | Q2 2015 | $7.7m | $883k | |
| AQR Capital Management LLC | Q2 2013 | $318m | last listed Q3 2022 | |
| Renaissance Technologies LLC | Q2 2013 | $274m | last listed Q1 2021 | |
| D1 Capital Partners LP | Q4 2024 | $173m | last listed Q1 2025 | |
| D. E. Shaw & Co. | Q2 2016 | $150m | last listed Q4 2025 | |
| Viking Global Investors LP | Q1 2021 | $148m | last listed Q1 2023 | |
| Acadian Asset Management LLC | Q4 2013 | $146m | last listed Q4 2020 | |
| Point72 Asset Management LP | Q3 2014 | $87m | last listed Q4 2025 | |
| Two Sigma Investments LP | Q2 2013 | $74m | last listed Q1 2025 | |
| Woodline Partners LP | Q4 2020 | $70m | last listed Q4 2025 | |
| Balyasny Asset Management LLC | Q4 2013 | $66m | last listed Q4 2025 |
What CRL is worth
Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.
Build the comp set around CRL →How much of the picture this is
A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.
What to do with a name the funds are buying
Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More
The holdings, every quarter, and the week between
One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.
One email a week, free, and you can leave at any point.